Carotid Artery DiseasesCarotid Artery, InternalCerebral Revascularization
Ali Reza Tafreshi
NPI1104446475
- Part D claims, 2024
- 18
- Publications
- 57
- Clinical trials
- 3
- Industry payments
- $2,924
- State license
- 1
- Practice address
- 100 N Academy Ave, Danville, PA 17822-9800
- Practice phone
- Call (570) 271-6211
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Ali Tafreshi's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Ali Reza Tafreshi is a neurosurgeon in Danville, Pennsylvania
Ali Tafreshi practices in Danville, Pennsylvania.
Ali Tafreshi's NPI, 1104446475, was assigned on April 16, 2020. Ali Tafreshi holds Pennsylvania license HS000084L.
NPI and contact details
- NPI
- 1104446475NPI Registry (opens in a new tab)
- NPI enumeration date
- April 16, 2020
- NPI status
- Active
- Practice phone
- (570) 271-6211
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Ali Reza Tafreshi's practice address is in Danville, Pennsylvania
Ali Tafreshi's practice address in the NPI Registry is 100 N Academy Ave, Danville, PA 17822-9800. The practice phone is (570) 271-6211.
- NPI Registry address100 N Academy Ave, Danville, PA 17822-9800Phone(570) 271-6211
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Ali Reza Tafreshi's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Ali Tafreshi practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Ali Tafreshi's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Ali Tafreshi practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Ali Reza Tafreshi is one of 367 neurosurgeons in Pennsylvania
Neurological surgery is Ali Tafreshi's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Ali Tafreshi is licensed in Pennsylvania.
Specialties and state licenses
- Neurological surgery, PennsylvaniaPrimary
Neurosurgeons near Ali Tafreshi
Counts of neurosurgeons with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Ali Reza Tafreshi wrote 18 Medicare Part D claims in 2024
In 2024, Ali Tafreshi wrote 18 Medicare Part D claims for 14 patients. 100% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $29 in total drug cost. In 2023, CMS named 13 claims across 1 drug.
Part D claims, 202418
Drugs named by CMS1
Total drug cost$29
Part D patients14
Ali Tafreshi's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Ali Tafreshi's Part D claims, 2024
- Opioids61%11 of 18 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 132024: 1115%
Drugs named by CMS: 1 in 2024, 1 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Find neurosurgeons like Ali Tafreshi by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Ali Reza Tafreshi has 57 publications on record
Dmand AI links 57 papers to Ali Tafreshi, published from 2010 to 2025. 2020 was the busiest year, with 9. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Lung Neoplasms and Carcinoma, Non-Small-Cell Lung. Ali Tafreshi has published most often in J Glaucoma. Ali Tafreshi's most frequent co-authors are Robert N. Weinreb, MD, Seth Colton Ransom, MD and Felipe Andrade Medeiros, MD.
Papers57
Years published2010 to 2025
Ali Tafreshi's papers by year, 2016 to 2025
Topics Ali Tafreshi writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Lung Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Glaucoma, Open-Angle
- Intraocular Pressure
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents
- Tonometry, Ocular
Ali Tafreshi's most frequent co-authors
- Robert N. Weinreb, MD14 shared papers
- Seth Colton Ransom, MD10 shared papers
- Felipe Andrade Medeiros, MD7 shared papers
Recent publications by Ali Tafreshi
AminopyridinesAntineoplastic AgentsAustralia
Amyloid beta-PeptidesEye BanksFluorescent Dyes
Antibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsCarcinoma, Non-Small-Cell Lung
See who Ali Tafreshi researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Ali Tafreshi works with, so you can find a warm path to the right neurosurgeons.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Ali Reza Tafreshi has worked on 3 clinical trials
Dmand AI links Ali Tafreshi to 3 clinical trials, 2 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Breast Neoplasms, Non-Muscle Invasive Bladder Neoplasms and Prostatic Neoplasms.
Conditions in Ali Tafreshi's trials
- Breast Neoplasms
- Non-Muscle Invasive Bladder Neoplasms
- Prostatic Neoplasms
- Breast Diseases
- Carcinoma in Situ
Investigators on the most trials with Ali Tafreshi
Recent clinical trials with Ali Tafreshi
Randomised Phase 3 Trial of Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer: ENZAMET (opens in a new tab)
Active, not recruitingPhase 3
Prostatic NeoplasmsProstatic DiseasesEnzalutamideLHRHA or Surgical CastrationNSAA
Named Patient Use Program to Provide Abemaciclib for the Treatment of Metastatic Breast Cancer (opens in a new tab)
Approved for marketing
Breast NeoplasmsBreast DiseasesAbemaciclib
Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin (opens in a new tab)
Active, not recruitingPhase 3
Non-Muscle Invasive Bladder NeoplasmsCarcinoma in SituCretostimogene Grenadenorepvec
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Ali Reza Tafreshi received $2,924 in industry payments from 2021 to 2025
CMS Open Payments shows 33 general payments to Ali Tafreshi from 3 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 67% of the total. Medtronic, Inc. paid the most, $2,226.
General payments to Ali Tafreshi by program year, 2021 to 2025
General payments to Ali Tafreshi by kind, 2021 to 2025
$2.9Kin total
- Food and beverage$1,94567%
- Travel and lodging$97933%
Companies that paid Ali Tafreshi the most, 2021 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Ali Reza Tafreshi's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Ali Reza Tafreshi
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Ali Reza Tafreshi's NPI number?
Ali Reza Tafreshi's NPI number is 1104446475. It was assigned on April 16, 2020, and it is active in the NPI Registry.
What does Ali Reza Tafreshi specialize in?
Ali Reza Tafreshi is a neurosurgeon in Danville, Pennsylvania. The primary specialty in the NPI Registry is Neurological Surgery Physician (taxonomy code 207T00000X).
Where does Ali Reza Tafreshi practice?
Ali Tafreshi practices at 100 N Academy Ave, Danville, PA 17822-9800.
What is Ali Reza Tafreshi's office phone number?
The practice phone on file for Ali Tafreshi is (570) 271-6211.
What is Ali Reza Tafreshi's medical license number?
Ali Tafreshi holds Pennsylvania license HS000084L.
What drugs does Ali Reza Tafreshi prescribe most?
In 2024 Medicare Part D data, Ali Tafreshi's most prescribed drugs by claims were Oxycodone HCl.
Has Ali Reza Tafreshi received payments from drug or device companies?
CMS Open Payments shows $2,924 in general payments to Ali Tafreshi from 3 companies from 2021 to 2025. The largest total came from Medtronic, Inc.
How long has Ali Reza Tafreshi been practicing?
Ali Tafreshi's NPI was assigned in 2020.
Does Ali Reza Tafreshi do research?
Dmand AI links 57 publications to Ali Tafreshi, published from 2010 to 2025. Ali Tafreshi has worked on 3 clinical trials.
Who does Ali Reza Tafreshi publish with?
Ali Tafreshi's most frequent co-authors are Robert N. Weinreb, MD (14 shared papers), Seth Colton Ransom, MD (10 shared papers) and Felipe Andrade Medeiros, MD (7 shared papers).
Selling to neurological surgery practices?
See neurosurgeons in Pennsylvania by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card